Bio-Techne Corp.
Cash Flow Statement
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $54.6M | $51.0M | $38.0M | $38.2M | $-17.7M | $22.6M | $34.9M | $33.6M |
| Depreciation & Amortization | $24.1M | $24.2M | $24.7M | $24.3M | $27.1M | $27.6M | $27.1M | $28.1M |
| Depreciation | — | — | — | — | — | — | — | — |
| Amortization | $15.2M | $15.5M | $15.5M | $15.5M | $18.0M | $19.2M | $18.9M | $20.0M |
| Stock-Based Compensation | $5.2M | $10.5M | $14.0M | $11.7M | $4.6M | $11.4M | $14.7M | $10.2M |
| Net Cash from Operating Activities | $95.4M | $86.7M | $82.4M | $27.6M | $98.2M | $41.1M | $84.3M | $63.9M |
| Investing Activities | ||||||||
| Capital Expenditures | $8.5M | $9.1M | $5.9M | $5.4M | $4.9M | $10.1M | $6.8M | $9.2M |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $-7.1M | $-5.8M | $-5.9M | $605.0K | $406.0K | $-8.9M | $-5.0M | $-21.7M |
| Financing Activities | ||||||||
| Dividends Paid | $12.5M | $12.5M | $12.5M | $12.4M | $12.4M | $12.6M | $12.7M | $12.7M |
| Stock Repurchases | $41.7M | $0 | $0 | $24.0K | — | — | — | — |
| Net Cash from Financing Activities | $-33.2M | $-42.7M | $-49.0M | $-44.2M | $-90.5M | $-68.0M | $-83.8M | $-11.6M |
| Net Change in Cash | $54.9M | $36.9M | $27.9M | $-17.2M | $21.5M | $-36.9M | $-10.0M | $35.7M |
| Free Cash Flow | $86.9M | $77.6M | $76.5M | $22.2M | $93.3M | $31.0M | $77.5M | $54.7M |